When Is Off-Label Drug Use in the Patient's Best Interest?

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)761-763
Number of pages3
JournalAmerican Journal of Ophthalmology
Volume147
Issue number5
DOIs
StatePublished - May 1 2009

Fingerprint

Off-Label Use
Drug Approval
Physician-Patient Relations
Vitreous Body
Choroidal Neovascularization
Medical Ethics
Macular Degeneration
Cost-Benefit Analysis
Tumor Necrosis Factor-alpha
Monoclonal Antibodies
Injections
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

When Is Off-Label Drug Use in the Patient's Best Interest? / Rosenfeld, Philip J; Goodman, Kenneth.

In: American Journal of Ophthalmology, Vol. 147, No. 5, 01.05.2009, p. 761-763.

Research output: Contribution to journalArticle

@article{b516168072aa40d99e7e93553763f67d,
title = "When Is Off-Label Drug Use in the Patient's Best Interest?",
author = "Rosenfeld, {Philip J} and Kenneth Goodman",
year = "2009",
month = "5",
day = "1",
doi = "10.1016/j.ajo.2009.01.011",
language = "English",
volume = "147",
pages = "761--763",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - When Is Off-Label Drug Use in the Patient's Best Interest?

AU - Rosenfeld, Philip J

AU - Goodman, Kenneth

PY - 2009/5/1

Y1 - 2009/5/1

UR - http://www.scopus.com/inward/record.url?scp=64349114475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64349114475&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2009.01.011

DO - 10.1016/j.ajo.2009.01.011

M3 - Article

C2 - 19376327

AN - SCOPUS:64349114475

VL - 147

SP - 761

EP - 763

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 5

ER -